Should diabetic women with breast cancer have their own intervention studies?

David A. Potter, Douglas Yee, Zhijun Guo, Mariangellys Rodriguez

Research output: Contribution to journalArticlepeer-review

Abstract

This commentary on 'Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity' by Nogueira et al., published in this issue of Endocrine-Related Cancer, addresses the challenges of translating diet, exercise, and pharmacologic trials in diabetic mouse mammary tumor models to human studies. We propose that trials specifically designed to test such interventions in diabetic women with breast cancer would be valuable and informative.

Original languageEnglish (US)
Pages (from-to)C13-C17
JournalEndocrine-related cancer
Volume19
Issue number1
DOIs
StatePublished - Feb 2012

Bibliographical note

Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Should diabetic women with breast cancer have their own intervention studies?'. Together they form a unique fingerprint.

Cite this